In chronic renal failure, the inability to produce calcitriol (1,25-dihydroxyvitamin D) leads to renal osteodystrophy. Calcitriol deficiency results in low calcium and high phosphate levels in the blood, stimulating parathyroid hormone secretion and causing demineralization of bones. To treat this, vitamin D must be accompanied by phosphate reduction through a low-phosphate diet and phosphate binders, as high phosphate levels can lead to soft tissue calcification when combined with low calcium levels.